Covington & Burling (Washington)

Richard Kingham

Covington & Burling (Washington)
Lawyer (Of Counsel)

Richard Kingham is a senior counsel who concentrates on food and drug law. He has acted for most of the major pharmaceutical manufacturers and biotechnology companies in the United States and Europe, as well as trade associations such as the Pharmaceutical Research and Manufacturers of America (PhRMA), the Consumer Healthcare Products Association (CHPA), and the National Pharmaceutical Council. He has represented pharmaceutical manufacturers in administrative proceedings, criminal prosecutions, and congressional hearings, served on committees of the World Health Organization, the Institute of Medicine of the National Academy of Sciences, and the National Institutes of Health and taught pharmaceutical law at universities in the U.S. and UK.

Linked authors

Covington & Burling (Washington)
Covington & Burling (London)
Covington & Burling (Brussels)
Covington & Burling (Washington)
Covington & Burling (Washington)

Articles

20 Bulletin

Michael Labson, Geoffrey Hobart, Eric Holder, Mark Lynch, Richard Kingham, Peter Safir, Theodore Voorhees Jr, James R. Dean, David W. Addis, Ethan M. Posner The US FTC announces its intention to conduct an extensive study of the economic effects of authorized generic pharmaceuticals

20

On April 4, 2006, the FTC published notice of its intention to conduct an extensive study of the economic effects of authorized generic pharmaceuticals. See 71 Fed. Reg. 16,779 (April 4, 2006). The initial stage of the study would involve detailed information requests, akin to subpoenas, to as (...)

Send a message